JPRN-UMIN000044264已完成未知
Comparison of clinical efficacy and safety of weekly GLP-1 receptor agonists dulaglutide and semaglutide - Comparison of clinical efficacy and safety of dulaglutide and semaglutide
Kawasai Medical School0 个研究点目标入组 120 人开始时间: 2021年6月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
The primary endpoint was the difference of HbA1c level between 2 groups at 24 weeks. The HbA1c level at 24 weeks was significantly lower in S than D. Reduction in BMI and VFA levels were also more significant in S, BMI: 29.2 to 28.8 vs. 29.4 to 28.1
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes patient Patients using insulin Patients treated with GLP-1 receptor agonist within 3 months Patients with a history of severe ketosis, diabetic coma, or precoma within the last 6 months Pregnant or potentially pregnant women and lactating patients Diabetic patients with specific mechanisms and diseases (exocrine pancreatic disease, endocrine disease, drug-induced, hereditary) Cases during steroid administration Patients with malignant tumors Patients with severe infections, before and after surgery, and with serious trauma Patients with severe liver damage Other cases judged to be inappropriate
研究者
相似试验
已完成
4 期
Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyDiabetes Mellitus, Type 1NCT00539448Sanofi98
已完成
3 期
32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes MellitusDiabetes Mellitus, Type 1NCT00537251Sanofi80
已完成
不适用
To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)Diabetes MellitusNCT05859165Société des Produits Nestlé (SPN)233
终止
4 期
Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlDiabetes Mellitus, Type 2NCT00283049Sanofi390
Unknown
4 期
Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus AlogliptinType 2 Diabetes MellitusNCT02426294Pusan National University Hospital154